N-Acetyl-L-Cysteine → N-Acetyl-L-Cysteine
Reaction equation
[OH-:1].[Ca+2:2].[OH-].[OH-].[Mg+2:5].[OH-].[C:7]([NH:10][C@H:11]([C:14]([OH:16])=[O:15])[CH2:12][SH:13])(=[O:9])[CH3:8]>OP([O-])(O)=O.OP([O-])([O-])=O.[Na+].[Na+].[Na+].[Cl-].[Cl-].[K+].[K+].O>[OH-:9].[Ca+2:2].[OH-:1].[C:7]([NH:10][C@H:11]([C:14]([OH:16])=[O:15])[CH2:12][SH:13])(=[O:9])[CH3:8].[OH-:9].[Ca+2:2].[OH-:9].[OH-:9].[Mg+2:5].[OH-:9]Participants
Reactant 3
Product 3
Reagents, catalysts & solvents 2
Procedure
In one aspect, a hydrogel composition for use as a support scaffold for developing mineralizing connective tissue is provided. The basic hydrogel solution consists of a 30% (w/v) solution of albumin in phosphate-buffered saline containing 40 mM N-acetylcysteine mixed in a 1:1 ratio with a suspension of mineral salt(s) in water. Either of two mineral salt suspensions stimulates hydrogel formation and alters the characteristics of the gel: (1) 0.5 g calcium hydroxide suspended in 10 mL water or (2) 0.5 g calcium hydroxide suspended in 10 mL water and 0.5 g magnesium hydroxide suspended in 10 mL water, then combined in ratios of 2.5:1 up to 6:1 calcium hydroxide to magnesium hydroxide. The albumin/N-acetylcysteine solution is mixed 1:1 with either of the mineral salt solutions, yielding a final volume ratio of (1) 1:1 for the albumin/N-acetylcysteine to calcium hydroxide mixture or (2) multiple volume ratios of albumin/N-acetylcysteine to the combined calcium hydroxide/magnesium hydroxide suspension. The addition of small amounts of other additives (e.g., fibrinogen, beta-glycerol phosphate, 2-phosphoascorbic acid) does not affect formation of the hydrogel.
Workup
- customis provided
Sources & evidence
- ORD record
- ord-4f8482c1ae794ebe90ec48bbd3f50e0b
- Source dataset
- uspto-grants-2013_06
- Patent number
- US08454980B2
Reaction notes
Loading…